BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 28573829)

  • 1. Comparative proteomic profiling of the serum differentiates pancreatic cancer from chronic pancreatitis.
    Saraswat M; Joenväärä S; Seppänen H; Mustonen H; Haglund C; Renkonen R
    Cancer Med; 2017 Jul; 6(7):1738-1751. PubMed ID: 28573829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proteomic comparison of formalin-fixed paraffin-embedded pancreatic tissue from autoimmune pancreatitis, chronic pancreatitis, and pancreatic cancer.
    Paulo JA; Kadiyala V; Brizard S; Banks PA; Steen H; Conwell DL
    JOP; 2013 Jul; 14(4):405-14. PubMed ID: 23846938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling.
    Pan S; Chen R; Crispin DA; May D; Stevens T; McIntosh MW; Bronner MP; Ziogas A; Anton-Culver H; Brentnall TA
    J Proteome Res; 2011 May; 10(5):2359-76. PubMed ID: 21443201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
    Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
    Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling.
    Hocker JR; Postier RG; Li M; Lerner MR; Lightfoot SA; Peyton MD; Deb SJ; Baker CM; Williams TL; Hanas RJ; Stowell DE; Lander TJ; Brackett DJ; Hanas JS
    Cancer Lett; 2015 Apr; 359(2):314-24. PubMed ID: 25637792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology.
    Ferri MJ; Saez M; Figueras J; Fort E; Sabat M; López-Ben S; de Llorens R; Aleixandre RN; Peracaula R
    PLoS One; 2016; 11(1):e0147214. PubMed ID: 26808421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbohydrate antigen 19-9 for differential diagnosis of pancreatic carcinoma and chronic pancreatitis.
    Su SB; Qin SY; Chen W; Luo W; Jiang HX
    World J Gastroenterol; 2015 Apr; 21(14):4323-33. PubMed ID: 25892884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics portrait of archival lesions of chronic pancreatitis.
    Pan S; Chen R; Stevens T; Bronner MP; May D; Tamura Y; McIntosh MW; Brentnall TA
    PLoS One; 2011; 6(11):e27574. PubMed ID: 22132114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation, Tumoral Markers and Interleukin-17, -10, and -6 Profiles in Pancreatic Adenocarcinoma and Chronic Pancreatitis.
    Tanţău A; Leucuţa DC; Tanţău M; Boţan E; Zaharie R; Mândruţiu A; Tomuleasa IC
    Dig Dis Sci; 2021 Oct; 66(10):3427-3438. PubMed ID: 33184795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytically validated protein biomarkers of chronic pancreatitis and pancreatic cancer for potential clinical diagnosis with mass spectrometry.
    Chou CY; Chang CT; Chen CJ
    Rapid Commun Mass Spectrom; 2020 Apr; 34 Suppl 1():e8580. PubMed ID: 31502717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics as a systems approach to pancreatitis.
    Williams JA
    Pancreas; 2013 Aug; 42(6):905-11. PubMed ID: 23851428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of matrix metalloproteinase 7 in plasma and pancreatic juice as a biomarker for pancreatic cancer.
    Kuhlmann KF; van Till JW; Boermeester MA; de Reuver PR; Tzvetanova ID; Offerhaus GJ; Ten Kate FJ; Busch OR; van Gulik TM; Gouma DJ; Crawford HC
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):886-91. PubMed ID: 17507610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SELDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of a boosting decision tree model for diagnosis of pancreatic cancer.
    Qian JY; Mou SH; Liu CB
    Asian Pac J Cancer Prev; 2012; 13(5):1911-5. PubMed ID: 22901146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Small Proteins and Peptides in the Differentiation of Patients with Intraductal Mucinous Neoplasms of the Pancreas, Chronic Pancreatitis and Pancreatic Adenocarcinoma.
    Fania C; Pezzilli R; Melzi d'Eril G; Gelfi C; Barassi A
    Dig Dis Sci; 2018 Apr; 63(4):920-933. PubMed ID: 29417328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth differentiation factor (GDF-15) concentration combined with Ca125 levels in serum is superior to commonly used cancer biomarkers in differentiation of pancreatic mass.
    Hogendorf P; Durczyński A; Skulimowski A; Kumor A; Poznańska G; Strzelczyk J
    Cancer Biomark; 2018 Feb; 21(3):505-511. PubMed ID: 29171983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA biomarkers in whole blood for detection of pancreatic cancer.
    Schultz NA; Dehlendorff C; Jensen BV; Bjerregaard JK; Nielsen KR; Bojesen SE; Calatayud D; Nielsen SE; Yilmaz M; Holländer NH; Andersen KK; Johansen JS
    JAMA; 2014 Jan 22-29; 311(4):392-404. PubMed ID: 24449318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum protein signatures differentiating autoimmune pancreatitis versus pancreatic cancer.
    Felix K; Hauck O; Fritz S; Hinz U; Schnölzer M; Kempf T; Warnken U; Michel A; Pawlita M; Werner J
    PLoS One; 2013; 8(12):e82755. PubMed ID: 24349355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of platelet-lymphocyte ratio and CA 19-9 in differentiating benign from malignant head masses in patients with chronic pancreatitis.
    Kakkat S; Rajan R; Sindhu RS; Natesh B; Raviram S
    Indian J Gastroenterol; 2017 Jul; 36(4):263-267. PubMed ID: 28916969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Mayerle J; Kalthoff H; Reszka R; Kamlage B; Peter E; Schniewind B; González Maldonado S; Pilarsky C; Heidecke CD; Schatz P; Distler M; Scheiber JA; Mahajan UM; Weiss FU; Grützmann R; Lerch MM
    Gut; 2018 Jan; 67(1):128-137. PubMed ID: 28108468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.